Infective endocarditis (IE) is a serious infectious disease with significant mortality and morbidity placing a burden on healthcare systems. Outpatient antimicrobial therapy in selected patients has been shown to be safe and beneficial to both patients and the healthcare system. In this article, we review the literature on the model of care for outpatient parenteral antimicrobial therapy in infective endocarditis and propose that systems of care be developed based on local resources and all patients admitted with infective endocarditis be screened appropriately for outpatient antimicrobial therapy
Despite developments in antibiotics and surgery, the treatment regimen for infective endocarditis co...
Since its introduction in the 1970s, outpatient parenteral antimicrobial therapy (OPAT) has become a...
AbstractHome and outpatient parenteral antibiotic therapy offers potential cost savings as well as i...
Infective endocarditis (IE) is a serious infectious disease with significant mortality and morbidity...
International audienceObjectives - We evaluated the benefit/risk ratio of outpatient parenteral anti...
Outpatient parenteral antibiotic treatment (OPAT) programs are increasingly used to manage infective...
The incidence of infectious endocarditis is fairly stable over the past decades. It is estimated at ...
WHAT IS KNOWN AND OBJECTIVE: Outpatient parenteral therapy (OPAT) has become a safe and effective mo...
In healthcare, there has been a growing emphasis on establishing quality care at a low price. To ach...
commonplace in the UK, enabling those patients who would previously have been obliged to remain in h...
Thirty patients with endocarditis caused by penicillin-susceptible streptococci were enrolled in one...
Background: The epidemiology of infective endocarditis (IE) continues to evolve, with antimicrobial ...
We have witnessed major shifts in the delivery of health care from the hospital to community setting...
Etiological, microbiological and epidemiological factors changed over time, but mortality rates rema...
AbstractOBJECTIVESThe purpose of this study was to assess the quality of the management of infective...
Despite developments in antibiotics and surgery, the treatment regimen for infective endocarditis co...
Since its introduction in the 1970s, outpatient parenteral antimicrobial therapy (OPAT) has become a...
AbstractHome and outpatient parenteral antibiotic therapy offers potential cost savings as well as i...
Infective endocarditis (IE) is a serious infectious disease with significant mortality and morbidity...
International audienceObjectives - We evaluated the benefit/risk ratio of outpatient parenteral anti...
Outpatient parenteral antibiotic treatment (OPAT) programs are increasingly used to manage infective...
The incidence of infectious endocarditis is fairly stable over the past decades. It is estimated at ...
WHAT IS KNOWN AND OBJECTIVE: Outpatient parenteral therapy (OPAT) has become a safe and effective mo...
In healthcare, there has been a growing emphasis on establishing quality care at a low price. To ach...
commonplace in the UK, enabling those patients who would previously have been obliged to remain in h...
Thirty patients with endocarditis caused by penicillin-susceptible streptococci were enrolled in one...
Background: The epidemiology of infective endocarditis (IE) continues to evolve, with antimicrobial ...
We have witnessed major shifts in the delivery of health care from the hospital to community setting...
Etiological, microbiological and epidemiological factors changed over time, but mortality rates rema...
AbstractOBJECTIVESThe purpose of this study was to assess the quality of the management of infective...
Despite developments in antibiotics and surgery, the treatment regimen for infective endocarditis co...
Since its introduction in the 1970s, outpatient parenteral antimicrobial therapy (OPAT) has become a...
AbstractHome and outpatient parenteral antibiotic therapy offers potential cost savings as well as i...